Literature DB >> 8098234

The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides.

D X West1, A E Liberta, K G Rajendran, I H Hall.   

Abstract

Thiosemicarbazone complexes of copper(II) were shown to be potent cytotoxic/antineoplastic agents against the growth of murine and human tumor cells. Selectivity of some agents was demonstrated against specific solid tumor growth. In L1210 lymphoid leukemia cells the copper complexes preferentially inhibited DNA synthesis with their major effects on the purine de novo pathway at PRPP amido transferase, IMP dehydrogenase and dihydrofolate reductase. The reductions of purines correlated positively with inhibition of DNA synthesis and cytotoxicity of the agents tested. DNA itself was fragmented after incubation with the drug; however, no binding of the agent to nucleotide bases or intercalation between base pairs was evident.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098234     DOI: 10.1097/00001813-199304000-00017

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

1.  Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.

Authors:  Brian M Zeglis; Vadim Divilov; Jason S Lewis
Journal:  J Med Chem       Date:  2011-03-10       Impact factor: 7.446

2.  The role of oxidative stress in activity of anticancer thiosemicarbazones.

Authors:  Katarzyna Malarz; Anna Mrozek-Wilczkiewicz; Maciej Serda; Marta Rejmund; Jaroslaw Polanski; Robert Musiol
Journal:  Oncotarget       Date:  2018-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.